Oscillometry-defined Small Airway Dysfunction in Tobacco-exposed Adults with Impaired or Preserved Airflow
Mustafa Abdo(Heidelberg University), Jens Vogel‐Claussen(Medizinische Hochschule Hannover), Susanne Stiebeler(LungenClinic Grosshansdorf), Benjamin Waschki(University of Lübeck), Klaas Franzen(University Hospital Schleswig-Holstein), Martin Reck(German Center for Lung Research), Benjamin‐Alexander Bollmann(Medizinische Hochschule Hannover), Sabine Dettmer(Medizinische Hochschule Hannover), Sabine Bohnet(University Hospital Schleswig-Holstein), Henrik Watz(University of Lübeck), Katharina May(University Hospital Schleswig-Holstein), Miriam Annabella Marcella Guess(University Hospital Schleswig-Holstein), Frederik Trinkmann(Heidelberg University), Johannes Roeben(University Hospital Schleswig-Holstein), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel)
Cited by 8
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
|Journal of Clinical Oncology|2009|1.5k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856